Molecular Diagnostics Market Is Expected To Reach US$ 12,358.6 Mn By 2025

More documents

Recommendations

Info

Infectious disease diagnostics is the leading the segment among the application areas due to factors such as increasing number of infectious disease, and growing demand for infectious disease diagnosis in tropical countries as the weather favors the microbes and vectors transmitting such diseases. Oncology will be the fastest growing segment in the application market through the forecast period 2017-2025, majorly due to factors such as rising prevalence of cancer, increasing demand for pharmacogenomics and technological advancement in the molecular diagnostic devices. Polymerase chain reaction holds the largest market in the technology segment for the base year 2016 due to factors such as its potential to detect rare diseases, rising demand for personalized medication and pharmacogenomics, and its potential in establishing the DNA sequence of patients, which will be helpful in the prevention of several life threatening diseases. Microarray will be the fastest growing technology segment throughout the forecast period 2017-2025 as it is helpful in diagnosing different types of cancer on the basis of the genetic pattern and increasing demand for toxicogenomics, which helps in determining the antibiotics of choice in cases of multiple drug resistance. Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58588 The global molecular diagnostics market is technologically driven and includes major players such as Abbott Laboratories, Inc., Novartis AG, Alere, Inc., Siemens Healthcare, Bayer AG, and F.Hoffman La Roche Ltd. etc. are few market leaders in molecular diagnostic market and compete to augment their foothold in the market. Key Market Movements: - Rising prevalence of patients suffering with critical illnesses requiring immediate diagnosis - Increase in the number of research and academic institutes utilizing diagnostic reagents and instruments - Technological advancement in the nature of diagnostic reagents and kits providing better results - Affordable reimbursement scenario
By Product Reagents and Kits Instruments Services and Software By Application Infectious Diseases Oncology Next Generation Sequencing DNA Sequencing Microbiology Others By Technology Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology In situ Hybridization Microarrays Others By Geography North America Europe Asia Pacific Middle East & Africa (MEA) Latin America Download Free PDF Request for Customization: https://www.credenceresearch.com/inquiry-before-buying/58588
Page 1: Molecular Diagnostics Market Is Exp

Molecular Diagnostics Market Is Expected To Reach US$ 12,358.6 Mn By 2025

Create successful ePaper yourself

Delete template?

Save as template?